Wf. Salminen et al., IMMUNOCHEMICAL COMPARISON OF 3'-HYDROXYACETANILIDE AND ACETAMINOPHEN BINDING IN MOUSE-LIVER, Drug metabolism and disposition, 26(3), 1998, pp. 267-271
The hepatotoxicity of the analgesic acetaminophen is believed to be me
diated by covalent binding to critical proteins. Radiolabeled 3'-hydro
xyacetanilide, a regioisomer of acetaminophen, covalently binds to pro
teins at levels similar to those of acetaminophen, but without toxicit
y. Covalent binding has recently been detected by Western blot to a 50
-kDa microsomal protein that comigrated with CYP2E1 and was accompanie
d by a loss of the CYP2E1 activity. However, radiolabel studies previo
usly indicated that a significant amount of the radiolabel is lost dur
ing electrophoresis. In the present study, 3'-hydroxyacetanilide coval
ent binding was detected immunohistochemically in liver using an anti-
acetaminophen antiserum. 3'-Hydroxyacetanilide (1000 mg/kg, ip) admini
stration to mice resulted in panlobular immunostaining in liver, with
the single layer of hepatocytes surrounding the central veins having t
he greatest intensity of staining. Staining was most intense at 1 hr a
nd somewhat decreased at 3 and 6 hr. In contrast, immunochemical stain
ing indicated that covalent binding of acetaminophen (250 mg/kg, ip) w
as confined to the centrilobular hepatocytes, the area of the ensuing
necrosis. Cobaltous chloride pretreatment decreased the total intensit
y of the panlobular immunostaining following 8'-hydroxyacetanilide. Th
e CYP2E1 inhibitor diallyl sulfide decreased the intensity of immunost
aining in the central vein area only. Western blot analysis indicated
diallyl sulfide also eliminated binding to the microsomal 50-kDa prote
in, These data are consistent with centrilobular binding of 3'-hydroxy
acetanilide, mediated in part by CYP2E1, and panlobular binding, media
ted by other P450 enzymes.